Disturbances of taste and smell induced by drugs

Pharmacotherapy

Volumn 17, Issue 3, 1997, Pages 482-496

  Ackerman, Bruce H ^a,b   Kasbekar, Nishaminy ^a  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALLOPURINOL; ALPHA INTERFERON; AMILORIDE; AMLODIPINE; AMPHETAMINE DERIVATIVE; AMPHOTERICIN B; AMRINONE; AURANOFIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA LACTAM ANTIBIOTIC; BLEOMYCIN; BRETYLIUM; CADMIUM; CAPTOPRIL; CARBAMAZEPINE; CARBOPLATIN; CIPROFLOXACIN; CYTARABINE; DILTIAZEM; DOXYCYCLINE; ENALAPRIL; FELODIPINE; FLUNISOLIDE; METHOTREXATE; MEVINOLIN; NIFEDIPINE; SILVER NITRATE; TERBINAFINE; UNINDEXED DRUG;

AGEUSIA; ANOSMIA; DISEASE ASSOCIATION; DYSGEUSIA; HUMAN; HYPOGEUSIA; PATHOPHYSIOLOGY; REVIEW; SMELLING DISORDER; TASTE DISORDER; XEROSTOMIA;

HUMANS; OLFACTION DISORDERS; PHARMACEUTICAL PREPARATIONS; SMELL; TASTE; TASTE DISORDERS; XEROSTOMIA;

EID: 0031000521     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (126)

1. Bartoshuk LM, Beauchamp GK. Chemical senses. Annu Rev Psychol 1994;45:419-49.
2. Davidson TM, Murphy C, Jalowayski AA, Smell impairment. Can it be reversed? Postgrad Med 1995;98:107-9.
3. Mattes RD, Cowart BJ. Dietary assessment of patients with chemosensory disorders. J Am Diet Assoc 1994;94:50-6.
4. Mott AE, Grushka M, Sessle BJ. Diagnosis and management of taste disorders and burning mouth syndrome. Dent Clin North Am 1993;37:33-71.
5. Li C, Yousem DM, Doty RL, Kennedy DW. Neuroimaging in patients with olfactory dysfunction. AJR 1994;162:411-18.
6. Estrem SA, Renner G. Disorders of smell and taste. Otolaryngol Clin North Am 1987;20:133-47.
7. Baloh RW. The special senses. In: Wyngaarden JB, Smith LH, Bennett JC, eds. Cecil textbook of medicine, 19th ed. Philadelphia: WB Saunders, 1992:2098-9.
8. Russell MJ, Cummings BJ, Profitt BF, Wysocki CJ, Gilbert AN, Cotman CW. Life span changes in the verbal categorization of odors. J Gerontol 1993;48:49-53.
9. Ship JA, Weiffenbach JM. Age, gender, medical treatment, and medication effects on smell identification. J Gerontol 1993;48:M26-32.
10. Davidson TM, Murphy C. Olfactory impairment. West J Med 1993;159:71-2.
11. Yousem DM, Geckle RJ, Bilker W, McKeown DA, Doty RL. MR evaluation of patients with congenital hyposmia or anosmia. AJR 1996;166:439-43.
12. Deems DA, Doty RL, Settle RG, et al. Smell and taste disorders: a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg 1991;11:519-28.
13. Mott AE, Leopold DA. Disorders of taste and smell. Med Clin North Am 1991;75:13231-53.
14. Huttenbrink KB. Disorders of the sense of smell and taste [English abstract]. Ther Umsch 1995;52:732-7.
15. Nordin S, Monsch AU, Murphy C. Unawareness of smell loss in normal aging and Alzheimer's disease: discrepancy between self-reporting and diagnosed smell sensitivity. J Gerontol 1995;50:P187-92.
16. Solomon GS. Anosmia in Alzheimer's disease. Percept Mot Skills 1994;79(3 pt 1):1249-50.
17. Weinstock RS, Wright HN, Smith DU. Olfactory dysfunction in diabetes mellitus. Physiol Behav 1993;53:17-21.
18. Warner MD, Peabody CA, Berger PA. Olfactory deficits and Down's syndrome. Biol Psychol 1988;23:836-9.
19. Van Damme PA, Freihofer HP. Disturbances of small and taste after high central midface fractures. J Craniomaxillofac Surg 1992;20:248-50.
20. Duncan HJ, Seiden AM. Long-term follow-up of olfactory loss secondary to head trauma and upper respiratory tract infection. Arch Otolaryngol Head Neck Surg 1995;121:1183-7.
21. Conrad P, Corwin J, Katz L, Serby M, LeFavour G, Rotrosen J. Olfaction and hemodialysis: baseline and acute treatment decrements. Nephron 1987;47:115-18.
22. Graham CS, Graham BG, Bartlett JA, Heald AE, Schiffman SS. Taste and smell losses in HIV infected patients. Physiol Behav 1995;58:287-93.
23. Hawkes CM. Diagnosis and treatment of Parkinson's disease: anosmia is a common finding. BMJ 1995;310(6977):447-52.
24. Tomita H. Zinc-deficient disorders of sense organs-dark adaptation, taste and smell disorders [Japanese with English abstract]. Nippon Rinsho 1996;54:141-7.
25. Corwin J, Loury M, Gilbert AN. Workplace, age, and sex as mediators of olfactory function: data from the National Geographic smell survey. J Gerontol 1995;50:P179-86.
26. Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 1995;10:283-7.
27. Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N. Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 1995;914:247-50.
28. Wheeler TT, Alberts MA, Dolan TA, McGorray SP. Dental, visual, auditory and olfactory complications of Paget's disease of bone. J Am Geriatr Soc 1995;43:1384-91.
29. Kretschmar JH. Anosmia as a symptom of incipient Pick's atrophy? Z Gerontol 1984;17:126-7.
30. Kopala L, Good K, Martzke J, Hurwitz T. Olfactory deficits in schizophrenia are not a function of task complexity. Schizophr Res 1995;17:195-9.
31. Nee LE, Scott J, Polinsky RJ. Olfactory dysfunction in the Shy-Drager syndrome. Clin Autonom Res 1993;3:281-2.
32. Weiffenbach JM, Fox PC. Odor identification ability among patients with Sjögren's syndrome. Arthritis Rheum 1993;36:1752-4.
33. Jafek BW, Moran DT, Eller PM, Rowley JC III, Jafek TB. Steroid-dependent anosmia. Arch Otolaryngol Head Neck Surg 1987;113:547-9.
34. Jovic NS, Ocic G. Disorders of olfactory function in penetrating head injuries sustained during war [Serbocroatian with English abstract]. Vojnosanit Pregl 1995;52:225-32.
35. Yamagishi M, Okazoe R, Ishizuka Y. Olfactory mucosa of patients with olfactory disturbance following head trauma. Ann Otolaryngol Rhinol Laryngol 1994;103(4 pt 1):279-84.
36. Moran DT, Jafek BW, Eller PM, Rowley JC III. Ultrastructural histopathology of human olfactory dysfunction. Microsc Res Tech 1992;23:103-10.
37. Schwartz GE, Bell IR, Dikman ZV, Fernandez M, Kline JP, Peterson JM. EEG responses to low-level chemicals in normals and cacosmics. Toxicol Ind Health 1994;10:633-43.
38. Varney NR. Prognostic significance of anosmia in patients with closed head trauma. J Clin Exp Neuropsychol 1988;10:250-4.
39. Seiden AM, Duncan HJ, Smith DV. Office management of taste and smell disorders. Otolaryngol Clin North Am 1992;25:817-35.
40. Comitto-Muniz JE, Cain WS. Efficacy of volatile organic compounds in evoking nasal pungency and odor. Arch Environ Health 1993;48:309-14.
41. Merren MD. Case 1: Bell's palsy and persistent loss of taste: Case 2: Bell's palsy, dramatic recovery with high dose steroid therapy. Am J Otol 1992;13:488.
42. Mattsson T, Arvidson K, Heimdahl A, Ljungman P, Dahllof G, Ringden O. Alterations in taste acuity associated with allogenic bone marrow transplantation. J Oral Pathol Med 1992;21:33-7.
43. Stubbs L. Taste changes in cancer patients. Nurs Times 1989;85:49-50.
44. Tomita H, Horikawa Y. Dissociated taste disorder. Auris Nasus Larynx 1986;13(suppl 1):S17-23.
45. Frankel DH, Mostofi RS, Lorincz AL. Oral Crohn's disease: report of two cases in brothers with metallic dysgeusia and a review of the literature. J Am Acad Dermatol 1985;12:260-8.
46. Lamey PJ, Darwazeh AM, Frier BM. Oral disorders associated with diabetes mellitus. Diabet Med 1992;9:40-6.
47. Dejima S, Yamamoto T, Maeoka Y, Maegaki Y, Hara T. Taste disturbance as an initial manifestation of Guillain-Barré syndrome in a 14 year old girl [Japanese with English abstract]. No To Hattatsu 1995;27:492-5.
48. Weinstein M. Epstein-Barr virus infection and neurologic disease. Neurol Res 1991;13:199-200.
49. Rasmussen N, Johnsen NJ, Bohr VA. Otologic sequelae after pneumococcal meningitis: a survey of 164 consecutive cases with a follow-up of 94 survivors. Laryngoscope 1991;101:876-82.
50. Constantinescu CS, Raps EC, Cohen JA, West SE, Doty RL. Olfactory disturbances as the initial or most prominent symptom of multiple sclerosis. J Neurol Neurosurg Psychiatry 1994;57:1011-12.
51. Fernando IN, Patel T, Billingham L, et al. The effect of head and neck irradiation on taste dysfunction: a prospective. Clin Oncol 1995;7:173-8.
52. Cain WS, Gant JF, Goodspeed RB, Leonard G. Evaluation of olfactory dysfunction in the Connecticut Chemosensory Clinical Research Center. Laryngoscope 1988;98:83-8.
53. Souder E, Yoder L. Olfaction: the neglected sense. J Neurosci Nurs 1992;24:273-80.
54. Ship JA. Gustatory and olfactory considerations: examination and treatment in general practice. J Am Dent Assoc 1993;124:55-62.
55. Stevens JC, Cruz LA, Hoffman JM, Patterson MQ. Taste sensitivity and aging: high incidence of decline revealed by repeated threshold measures. Chem Senses 1995;20:451-9.
56. Lewis IK, Hanlon JT, Hobbins MJ, Beck JD. Use of medications with potential oral adverse drug reactions in community-dwelling elderly. Special Care Dentistry 1993;13:171-6.
57. Wilcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994;272:292-6.
58. McClain CJ, McClain ML, Boosalis MG, Henning B. Zinc and the stress response. Scand J Work Environ Health 1993;19(suppl 1):132-3.
59. Fedoroff IC, Stoner SA, Anderson AE, Doty RL, Rolls BJ. Olfactory dysfunction in anorexia and bulimia nervosa. Int J Eat Disord 1995;18:71-7.
60. Kopala LC, Good K, Goldner EM, Birmingham CL. Olfactory identification ability in anorexia nervosa. J Psychiatry Neurosci 1995;20:283-6.
61. Kventon JF, Bartoshuk LM. The effect of unilateral chorda tympani damage on taste. Laryngoscope 1994;104(1 pt 1):25-9.
62. Cheng LH, Robinson PP. The distribution of fungiform papillae and taste buds on the human tongue. Arch Oral Biol 1991;36:583-9.
63. Miller IJ Jr, Reedy FE Jr. Variations in human taste bud density and taste intensity perception. Physiol Behav 1990;47:1213-19.
64. Miller IJ Jr. Human taste bud density across adult age groups. J Gerontol 1988;43:826-30.
65. Lelievre G, LeFloch JP, Perlmuter L, Peynègre R. Taste in healthy subjects. Influence of alcohol and tobacco consumption [French with English abstract] Ann Otolaryngol Chir Cervicofac 1989;106:541-6.
66. Levenson JL, Kennedy K. Dysosmia, dysgeusia and nifedipine. Ann Intern Med 1985;102:135-6.
67. Cocquyt VF, Van Belle SJ. Anosmia associated with alpha-interferon treatment. Ann Oncol 1994;5:863.
68. Vital Durand M. Recurrent anosmia under beta-blockers. Presse Med 1985;14:2064.
69. Mehta M, ed. PDR guide to drug interactions, side effects, indications. Montvale, NJ: Medical Economics, 1995.
70. Hoffman DL. Howard JR Jr, Sarma R, Riggs JE. Encephalopathy, myelopathy, optic neuropathy, and anosmia associated with cytosine arabinoside. Clin Neuropharmacol 1993;16:258-62.
71. Berman JL. Dysosmia, dysgeusia, and diltiazem. Ann Intern Med 1985;102:717-18.
72. Bleasel AF, McLeod JG, Brown ML. Anosmia after doxycycline use. Med J Aust 1990;152:440.
73. Weber R, Raschka C, Bonzel T. Medikamentos-toxisch bedingte Hyposmie nach Lovastatin. Laryngorhinootologie 1992;71:483-4.
74. Levinsons JL, Kennedy K. Dysosmia, dysgeusia, and nifedipine. Ann Intern Med 1985;102:135.
75. Westhofen M, Schafer H. Generalized argyrosis in man: neurological, ultrastructural, and x-ray microanalytical findings. Arch Otorhinolaryngol 1986;243:260-4.
76. Beutler M, Hartmann K, Kuhn M, Gartmann J. Taste disorders and terbinafine. BMJ 1993;307(6895):26.
77. Perkins KA, Epstein LH, Stiller RL, Fernstrom MH, Sexton JE, Jacob RG. Perception and hedonics of sweet and fat taste in smokers and nonsmokers following nicotine intake. Pharmacol Biochem Behav 1990;35:671-6.
78. Califano JA Jr. The wrong way to stay slim. N Engl J Med 1995;333:1214-16.
79. Mela DJ. Gustatory function and dietary habits in users and nonusers of smokeless tobacco. Am J Clin Nutr 1989;49:482-9.
80. Guidotti TL. Occupational exposure to hydrogen sulfide in the sour gas industry: some unresolved issues. Int Arch Occup Environ Health 1994;66:153-60.
81. Schiffman JS, Nagel HT. Effect of environmental pollutants on taste and smell. Otolaryngol Head Neck Surg 1992;106:693-700.
82. Harrison HN. Pharmacology of sulfadiazine silver. Arch Surg 1979;114:281-5.
83. Adelman BT. Altered taste and smell after anesthesia: cause and effect? Anesthesiology 1995;83:647-8.
84. Henkin RI. Altered taste and smell after anesthesia: cause and effect? Anesthesiology 1995;83:648-9.
85. Loesche WJ, Bromberg J, Terpenning MS, et al. Xerostomia, xerogenic medications and food avoidances in selected geriatric groups. J Am Geriatr Soc 1995;43:401-7.
86. McMurdo ME, Hutchinson GL, Lindsay G. Taste disturbance with acetazolamide. Lancet 1990;336:1190-1.
87. Niedzielska G. Study of smell and taste in alcoholics. Otolaryngol Pol 1987;41:318-22.
88. Manthorpe R, Horbov S, Sylvest J, Vinterberg H. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation. Scand J Rheumatol 1986;15:13-22.
89. Soni NK, Chatterji P. Gustotoxicity of bleomycin. J Otorhinolaryngol Related Specialties 1985;47:101-4.
90. Ljunggren O, Fredholm BB, Nordstedt C, Ljunghall S, Lerner UH. Role of protein kinase C in bradykinin-induced prostaglandin formation in osteoblasts. Eur J Pharmacol 1993;244:111-17.
91. Coulter DM. Eye pain with nifedipine and disturbance of taste with captopril: a mutually controlled study showing a method of postmarketing surveillance. Br Med J 1988;296(6629):1086-8.
92. Jackson D, Maher D, Matthews PG, McGrath BP, Johnston CI. Lack of cross sensitivity between captopril and enalapril. Aust N Z J Med 1988;18:21-7.
93. Rucinska EJ, Small R, Mulcahy WS, et al. Tolerability of long term enalapril maleate in patients resistant to other therapies and intolerant to captopril. Med Toxicol Adverse Drug Experience 1989;4:144-52.
94. Zazgornik J, Kaiser W, Biesenbach G. Captopril-induced dysgeusia. Lancet 1993;341(8859):1542.
95. Boyd I. Captopril-induced taste disturbance. Lancet 1993;342(8866):304.
96. Barajas Garcia-Talavera F. Ageusia in a patient treated with carbamazepine. Neurologia 1988;3:126-7.
97. Al-Tannir MA, Goodman HS. A review of chlorhexidine and its use in special populations. Special Care Dentistry 1994;14:116-22.
98. Guy JJ, Finci L, Sigwart U. Dysgeusia after high dose dipyridamole treatment. Arzneimittelforschung 1985;35:854.
99. Irvin JD, Viau JM. Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril. Am J Med 1986;81(suppl 4c):46-50.
100. Jones PB, McCloskey EV, Kanis JA. Translent taste loss during treatment with etidronate. Lancet 1987;2(8559):637.
101. Heise E, Schnuch A. Taste and olfactory disturbances after treatment for acne with isotretinoin, a 13-cis-isomer of retinoic acid. Eur Arch Otorhinolaryngol 1990;247:382-3.
102. Bressler B. An unusual side-effect of lithium. Psychosomatics 1980;21:688-9.
103. Schlienger RG, Saxer M, Haefeli WE. Reversible ageusia associated with losartan. Lancet 1996;347(8999):471-2.
104. Ewing RC, Janda SM, Henann NE. Ageusia associated with transdermal nitroglycerin. Clin Pharm 1989;8:146-7.
105. Steen VD, Blair S, Medsger TA Jr. The toxicity of D-penicillamine in systemic sclerosis. Ann Intern Med 1986;104:699-705.
106. Tauveron I, Thieblot P. Regression of propylthiouracil-induced dysgeusia after treatment with zinc. Therapie 1991;46:410.
107. Glover J, Dibble S, Miaskowski C, Geibert R. Changes in taste associated with intravenous administration of pentamidine. J Assoc Nurse AIDS Care 1995;6:43-8.
108. Morris JT, Kelly JW. Rifabutin-induced ageusia. Ann Intern Med 1993;119:171-2.
109. Marcus RW. Sulfasalazine induced taste disturbances. J Rheumatol 1991;18:634-5.
110. Magnasco LD, Magnasco AJ. Metallic taste associated with tetracycline therapy. Clin Pharm 1985;4:455-6.
111. Mela DJ. Smokeless tobacco and test sensitivity. N Engl J Med 1987;316:1165-6.
112. Sleight P. Vasodilators after myocardial infarction - ISIS IV. Am J Hypertens 1994;7(9 pt 2):102S-5.
113. Neil-Dwyer G, Marus A. ACE inhibitors in hypertension: assessment of taste and smell function in clinical trials. J Hum Hypertens 1989;1(suppl 3):169-76.
114. Mele PC, McDonough JR, McLean DB, O'Halloran KP. Cisplatin-induced conditioned taste aversion: attenuation by dexamethasone but not zacropride or GR38032F. Eur J Pharmacol 1992;218:229-36.
115. Alpers DH. Zinc and deficiencies of taste and smell. JAMA 1994;272:1233-4.
116. Henkin RI, Scheichter BJ, Freidwald WT, et al. A double-blind study of the effects of zinc sulfate on taste and smell function. Am J Med Sci 1976;272:285-99.
117. Trost BN. Glucose metabolism and calcium antagonists. Horm Metab Res 1990;22(suppl):48-56.
118. Davies SWV. Intravenous fluids and parageusia. Lancet 1994;343(8910):1432.
119. Hermans MP, Brichard SM, Colin I, Borgies P, Ketelslager JM, Lambert AE. Long-term reduction of microalbuminuria after 3 years of angiotensin converting enzyme inhibition by peridopril in hypertensive insulin-treated diabetic patients. Am J Med 1992;92(4B):102S-7.
120. Jungmann E, Usadel KH. Renal long-term effects of calcium antagonist treatment in patients with diabetes mellitus. Clin Invest 1992;70:942-8.
121. Lawless HT, Thomas CJ, Johnston M. Variation in odor thresholds for 1-carvone and cineole and correlations with suprathreshold intensity ratings. Chem Senses 1995;20:9-17.
122. Daniels TE. Diseases of the mouth and salivary glands. In: Baloh RW, ed. Cecil textbook of medicine, 19th ed. Philadelphia: WB Saunders, 1992:635-9.
123. Bonnano PC. Safe dosages of lidocaine for facial analgesia. J Craniofac Surg 1994;5:124-6.
124. Inman WH, Rawson NS, Wilton LV, Pearce GL, Speires CJ. Postmarketing surveillance of enalapril. I. Results of prescription-event monitoring. Br Med J 1988;297(6652):826-9.
125. Reeves PG, O'Dell BL. Effects of dietary zinc deprivation on the activity of angiotensin converting enzyme in serum of rats and guinea pigs. J Nutr 1986;116:128-34.
126. Henkin RI. Drug-induced taste and smell disorders. Incidence, mechanisms, and management related to treatment of sensory receptor dysfunction. Drug Safety 1994;11:318-77.